{"DataElement":{"publicId":"6776292","version":"1","preferredName":"POEMS Syndrome Characteristic Present Type","preferredDefinition":"A description of the POEMS syndrome characteristics that were present.","longName":"6776289v1.0:6776291v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6776289","version":"1","preferredName":"POEMS Syndrome Characteristic Present","preferredDefinition":"A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes.  It is often associated with osteosclerotic myeloma._The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._Being or existing in a specified place or at the specified time.","longName":"6776293v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6776293","version":"1","preferredName":"POEMS Syndrome Characteristic","preferredDefinition":"A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes.  It is often associated with osteosclerotic myeloma.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C80303:C25447","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"POEMS Syndrome","conceptCode":"C80303","definition":"A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. It is associated with plasma cell dyscrasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Characteristic","conceptCode":"C25447","definition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ABE44E8-7BCC-427D-E053-F662850A7BEE","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ABFC3BD-0E9E-4087-E053-F662850AFD20","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"KUMMEROA","dateModified":"2020-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6776291","version":"1","preferredName":"POEMS Syndrome Characteristic Type","preferredDefinition":"A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes.  It is often associated with osteosclerotic myeloma._The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._Something distinguishable as an identifiable class based on common qualities.","longName":"6776291v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hepatomegaly","valueDescription":"Hepatomegaly","ValueMeaning":{"publicId":"4291758","version":"1","preferredName":"Hepatomegaly","longName":"4291758","preferredDefinition":"Abnormal enlargement of the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatomegaly","conceptCode":"C3100","definition":"Abnormal enlargement of the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-63F7-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE44E8-7BBC-427D-E053-F662850A7BEE","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C57D-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Thrombocytosis / polycythemia","valueDescription":"Thrombocytosis And/Or Polycythemia Disease or Disorder","ValueMeaning":{"publicId":"6776304","version":"1","preferredName":"Thrombocytosis And/Or Polycythemia Disease or Disorder","longName":"6776304","preferredDefinition":"Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed): Used to indicate that either or both of two items or options may be valid.: Abnormally high mass or concentration of red blood cells in the blood, either due to an increase in erythropoiesis or a decrease in plasma volume.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytosis","conceptCode":"C35530","definition":"A hematology test result that indicates the presence of higher than normal platelet counts in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Polycythemia","conceptCode":"C26863","definition":"Abnormally high mass or concentration of red blood cells in the blood, either due to an increase in erythropoiesis or a decrease in plasma volume.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC02B9E-C58D-1395-E053-F662850A12A8","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C5A6-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Splenomegaly","valueDescription":"Splenomegaly","ValueMeaning":{"publicId":"4291755","version":"1","preferredName":"Splenomegaly","longName":"4291755","preferredDefinition":"Abnormal enlargement of the spleen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Splenomegaly","conceptCode":"C3384","definition":"Abnormal enlargement of the spleen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6386-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C5B0-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Sclerotic bone lesions","valueDescription":"Sclerosis Bone Lesion","ValueMeaning":{"publicId":"6776305","version":"1","preferredName":"Sclerosis Bone Lesion","longName":"6776305","preferredDefinition":"A pathological hardening or thickening of tissue, especially that of the interstitial substance.: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sclerosis","conceptCode":"C69309","definition":"A pathological hardening or thickening of tissue, especially that of the interstitial substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bone Lesion","conceptCode":"C43260","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC02B9E-C5BD-1395-E053-F662850A12A8","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C5D6-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Skin changes","valueDescription":"Skin Change","ValueMeaning":{"publicId":"6776306","version":"1","preferredName":"Skin Change","longName":"6776306","preferredDefinition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.: The act of alteration or modification; changed or altered in form or character.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC02B9E-C5E3-1395-E053-F662850A12A8","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C5FC-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Polyneuropathy","valueDescription":"Polyneuropathy","ValueMeaning":{"publicId":"6776308","version":"1","preferredName":"Polyneuropathy","longName":"6776308","preferredDefinition":"A disease or disorder affecting more than one nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polyneuropathy","conceptCode":"C26951","definition":"A disease or disorder affecting more than one nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC02B9E-C609-1395-E053-F662850A12A8","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C622-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Papilledema","valueDescription":"Papilledema","ValueMeaning":{"publicId":"2946002","version":"1","preferredName":"Papilledema","longName":"2946002","preferredDefinition":"Swelling around the optic disc, usually due to increased intracranial pressure or pressure on the optic nerve by a tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papilledema","conceptCode":"C3307","definition":"Swelling around the optic disc, usually due to increased intracranial pressure or pressure on the optic nerve by a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-41D0-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C62C-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Lymphadenopathy","valueDescription":"Lymphadenopathy","ValueMeaning":{"publicId":"4291752","version":"1","preferredName":"Lymphadenopathy","longName":"4291752","preferredDefinition":"An enlarged lymph node. Causes include viral and bacterial infections and cancers that affect the lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphadenopathy","conceptCode":"C50764","definition":"An enlarged lymph node. Causes include viral and bacterial infections and cancers that affect the lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6315-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C636-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Castleman's disease","valueDescription":"Angiofollicular Lymphoid Hyperplasia","ValueMeaning":{"publicId":"3210872","version":"1","preferredName":"Angiofollicular Lymphoid Hyperplasia","longName":"3210872","preferredDefinition":"A disorder characterized by lymphoid hyperplasia in the lymph nodes. There are two histologic variants recognized: the hyaline-vascular type and the plasma cell type. In the hyaline vascular type there are hyalinized vessels present in the lymphoid follicles. In the plasma cell type there is pronounced plasma cell proliferation. Clinically, the disease may be localized; manifested with localized lymphadenopathy, or multicentric; manifested with generalized lymphadenopathy, fever, organomegaly, and sometimes POEMS syndrome. In contrast to patients with localized disease who are usually cured following resection of the lesion, patients with the multicentric form of the disease may follow a progressive clinical course, complicated by infection, Kaposi sarcoma or lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Castleman Disease","conceptCode":"C3056","definition":"A disorder characterized by lymphoid hyperplasia in the lymph nodes. There are two histologic variants recognized: the hyaline-vascular type and the plasma cell type. In the hyaline vascular type there are hyalinized vessels present in the lymphoid follicles. In the plasma cell type there is pronounced plasma cell proliferation. Clinically, the disease may be localized; manifested with localized lymphadenopathy, or multicentric; manifested with generalized lymphadenopathy, fever, organomegaly, and sometimes POEMS syndrome. In contrast to patients with localized disease who are usually cured following resection of the lesion, patients with the multicentric form of the disease may follow a progressive clinical course, complicated by infection, Kaposi sarcoma or lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-ADA2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC02B9E-C64A-1395-E053-F662850A12A8","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","deletedIndicator":"No"},{"value":"Extravascular volume overload","valueDescription":"Extravascular Volume Overload","ValueMeaning":{"publicId":"6776774","version":"1","preferredName":"Extravascular Volume Overload","longName":"6776774","preferredDefinition":"Fluid volume expansion that occurs outside of the vascular system, which may be characterized by peripheral edema, pleural effusion, ascites, and pericardial effusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extravascular Volume Overload","conceptCode":"C161588","definition":"Fluid volume expansion that occurs outside of the vascular system, which may be characterized by peripheral edema, pleural effusion, ascites, and pericardial effusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AFC3DFD-39AF-3E11-E053-F662850A9DF7","latestVersionIndicator":"Yes","beginDate":"2019-06-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AFC3DFD-39C8-3E11-E053-F662850A9DF7","beginDate":"2019-06-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-10","modifiedBy":"ONEDATA","dateModified":"2019-06-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6776297","version":"1","preferredName":"POEMS Syndrome Characteristic Type","preferredDefinition":"A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes.  It is often associated with osteosclerotic myeloma.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.:Something distinguishable as an identifiable class based on common qualities.","longName":"C80303:C25447:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"POEMS Syndrome","conceptCode":"C80303","definition":"A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. It is associated with plasma cell dyscrasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Characteristic","conceptCode":"C25447","definition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ABFFD36-0747-3787-E053-F662850ACB9B","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ABE44E8-7BA6-427D-E053-F662850A7BEE","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","changeDescription":".","administrativeNotes":"7/18/2022: fixed the box symbol in PV.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify POEMS clinical features at the time of best response","type":"Alternate Question Text","description":"Specify POEMS clinical features at the time of best response","url":null,"context":"NHLBI"},{"name":"What was (were) the POEMS syn","type":"Preferred Question Text","description":"What was (were) the POEMS syndrome characteristics present?","url":null,"context":"NHLBI"},{"name":"Specify POEMS clinical features","type":"Alternate Question Text","description":"Specify POEMS clinical features","url":null,"context":"NHLBI"},{"name":"Specify POEMS clinical features","type":"Application Standard Question Text","description":"Specify POEMS clinical features","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ABD19CE-A66D-4279-E053-F662850A29DA","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"KUMMEROA","dateModified":"2020-02-03","changeDescription":". System generated def displayed as alt def.; . System generated def displayed as alt def.; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}